| (aac(3′)-IIa, ant(2″)-Ia) | aminoglycosides resistance genes |
| ADI | acceptable daily intake |
| AF | allocation factor |
| AMI | amikacin |
| AMP | ampicillin |
| AMX | amoxicillin |
| APEO | alkylphenol ethoxylates |
| AR | antibiotic resistance |
| ARB | antibiotic resistant bacteria |
| ARG | antibiotic resistance genes |
| ATM | aztreonam |
| BET | Betamethasone |
| blaTEM, blaIMP4, blaGES and blaNDM1 | β-lactams resistance genes |
| BMDL10 | lower limit of critical effect of the benchmark dose |
| BPA | bisphenol A |
| CAZ | ceftazidime |
| CCL | contaminant candidate list |
| CEC | contaminants of emerging concern |
| CET | ceftriaxone |
| CFL | cephalothin |
| CFO | cefoxitin |
| CFT | cefotaxime |
| CFU | colony forming unit |
| CIP | ciprofloxacin |
| CLA | clavulanic acid |
| CLI | clindamycin |
| CLO | chloramphenicol |
| CPM | cefepime |
| DEX | dexamethasone |
| DOX | doxycycline |
| DW | drinking water (water distributed by a WTP) |
| E1 | estrone |
| E2 | β-Estradiol |
| E2 -17-beta-estradiol | |
| EE2 | 17-alpha-ethinylestradiol |
| EFSA | European Food Safety Authority |
| ERI | erythromycin |
| ermB | macrolides resistance gene |
| GEN | gentamicin |
| GV | guideline values |
| IARC | International Agency for Research on Cancer |
| intI1, intI2 | integron genes |
| IPM | imipenem |
| KAN | kanamycin |
| LD | limit of detection |
| LQ | limit of quantification |
| LDTD | lowest daily therapeutic dose |
| LEV | levofloxacin |
| LOAEL | lowest observable adverse effect level |
| MAV | maximum acceptable values |
| ME | margin of exposure |
| MEC | maximum environmental concentration |
| MER | meropenem |
| NAL | nalidixic acid |
| NIT | nitrofurantoin |
| NOAEL | no observed adverse effect level |
| NOR | norfloxacin |
| NP | nonylphenol |
| NPX | naproxen |
| OC | occurrence concentration |
| PCR | polymerase chain reaction |
| P&EDC | pharmaceuticals and endocrine disrupting compounds |
| PEN | penicillin |
| PIP | piperacillin |
| PNEC | predicted no effect concentrations |
| PRE | prednisone |
| QCRA | Quantitative Chemical Risk Assessment |
| qnrS, qepA, gyrA | quinolone resistance genes |
| rRNA | ribossomal RNA |
| RQ | risk quotient |
| RW | raw water (water source that feeds a WTP) |
| SMX | sulfamethoxazole |
| SPM | spectinomycin |
| STM | streptomycin |
| SUL | sulfonamides |
| sulI | sulfonamide resistance gene |
| SUT | sulphazothrin |
| TBM | tobramycin |
| TET | tetracyclines |
| tetA, tetB, tetC, tetM, tetW | tetracycline resistance genes |
| TRI | trimethoprim |
| TZB | tazobactam |
| UF | uncertainty factor |
| USEPA | United States Environmental Protection Agency |
| VAN | vancomycin |
| WHO | World Health Organization |